JP2008517922A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517922A5
JP2008517922A5 JP2007538050A JP2007538050A JP2008517922A5 JP 2008517922 A5 JP2008517922 A5 JP 2008517922A5 JP 2007538050 A JP2007538050 A JP 2007538050A JP 2007538050 A JP2007538050 A JP 2007538050A JP 2008517922 A5 JP2008517922 A5 JP 2008517922A5
Authority
JP
Japan
Prior art keywords
number pta
designation number
patent deposit
deposit designation
atcc patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007538050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517922A (ja
JP4898691B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/037821 external-priority patent/WO2006047249A1/en
Publication of JP2008517922A publication Critical patent/JP2008517922A/ja
Publication of JP2008517922A5 publication Critical patent/JP2008517922A5/ja
Application granted granted Critical
Publication of JP4898691B2 publication Critical patent/JP4898691B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007538050A 2004-10-22 2005-10-21 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法 Expired - Fee Related JP4898691B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62155304P 2004-10-22 2004-10-22
US60/621,553 2004-10-22
PCT/US2005/037821 WO2006047249A1 (en) 2004-10-22 2005-10-21 Anti-il-22ra antibodies and binding partners and methods of using in inflammation

Publications (3)

Publication Number Publication Date
JP2008517922A JP2008517922A (ja) 2008-05-29
JP2008517922A5 true JP2008517922A5 (https=) 2011-09-22
JP4898691B2 JP4898691B2 (ja) 2012-03-21

Family

ID=35871017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538050A Expired - Fee Related JP4898691B2 (ja) 2004-10-22 2005-10-21 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法

Country Status (21)

Country Link
US (5) US7537761B2 (https=)
EP (1) EP1812476B1 (https=)
JP (1) JP4898691B2 (https=)
KR (1) KR101238684B1 (https=)
CN (1) CN101198625A (https=)
AT (1) ATE474856T1 (https=)
AU (1) AU2005299809B2 (https=)
BR (1) BRPI0516975A (https=)
CA (1) CA2584157C (https=)
CY (1) CY1110843T1 (https=)
DE (1) DE602005022475D1 (https=)
DK (1) DK1812476T3 (https=)
EA (1) EA015706B1 (https=)
ES (1) ES2347672T3 (https=)
IL (2) IL182503A (https=)
MX (1) MX2007004770A (https=)
NO (1) NO20072602L (https=)
PT (1) PT1812476E (https=)
UA (1) UA96122C2 (https=)
WO (1) WO2006047249A1 (https=)
ZA (1) ZA200704125B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
DE60123998T2 (de) * 2000-08-08 2007-09-06 Zymogenetics, Inc., Seattle Lösliche zcyctor 11 cytokinrezeptoren
JP2007525438A (ja) * 2003-03-24 2007-09-06 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法
WO2005052001A2 (en) 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
AU2005299809B2 (en) * 2004-10-22 2010-12-02 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
BRPI0619118A2 (pt) * 2005-12-02 2011-09-13 Genentech Inc composições e métodos para o tratamento de doenças e desordens associadas com a sinalização de citocina
WO2011047153A1 (en) * 2009-10-15 2011-04-21 President And Fellows Of Harvard College Methods for modulating autoimmunity
UA105405C2 (ru) * 2009-11-19 2014-05-12 Мерк Сероно С.А. Гуманизированное антитело против человеческого il-22ra
EP3409289B1 (en) 2010-02-26 2020-09-30 Novo Nordisk A/S Stable antibody containing compositions
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
AU2012204574B2 (en) 2011-01-04 2017-05-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating age-related macular degeneration
EP2686347B1 (en) 2011-03-16 2018-05-02 argenx BVBA Antibodies to cd70
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US10391168B1 (en) 2014-08-22 2019-08-27 University Of Bern Anti-CD70 combination therapy
US11510966B2 (en) * 2016-04-15 2022-11-29 Evive Biotechnology (Shanghai) Ltd Use of IL-22 in treating necrotizing enterocolitis
WO2017202813A1 (en) 2016-05-24 2017-11-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections
GB201612337D0 (en) 2016-07-15 2016-08-31 Argen-X N V Ant-il-22r antibodies
EP4053557A1 (en) * 2016-11-24 2022-09-07 Huvet Bio, Inc. Il-29 as a marker for a pancreatic disease
EP3615570A4 (en) 2017-04-25 2021-02-24 LBL Biotechnology Inc. USE OF IL-20 ANTAGONISTS FOR TREATMENT OF EYE DISEASES
GB201800649D0 (en) 2018-01-16 2018-02-28 Argenx Bvba CD70 Combination Therapy
KR20210019464A (ko) 2018-06-05 2021-02-22 바이오아트라, 인코퍼레이티드 항 il-22 항체, 항체 단편, 이의 면역접합체 및 이의 용도
CN110078832B (zh) * 2019-04-18 2021-12-14 江南大学 一类基于ZZ domain的二抗及其制备方法和应用
EP4106794A4 (en) 2020-02-19 2024-03-20 Evive Biotechnology (Shanghai) Ltd METHOD FOR TREATING TRANSPLANT AND HOST DISEASE
WO2022187374A1 (en) * 2021-03-02 2022-09-09 Dana-Farber Cancer Institute, Inc. Methods of treating red blood cell disorders
EP4704974A1 (en) 2023-03-08 2026-03-11 LEO Pharma A/S Il-22r antibody for use in treating atopic dermatitis

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
DE3572982D1 (en) 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
NZ212437A (en) 1985-06-17 1992-06-25 Mark Philip Best Site-directed antibody conjugates, and their preparation
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5116964A (en) 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5436155A (en) * 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5789192A (en) * 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
CA2258721C (en) 1996-07-12 2014-09-09 Genentech, Inc. Chimeric heteromultimer adhesins
US5843697A (en) 1996-07-17 1998-12-01 University Of Medicine And Dentistry Of New Jersey Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein
US5985614A (en) * 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
US5945511A (en) * 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US6133426A (en) 1997-02-21 2000-10-17 Genentech, Inc. Humanized anti-IL-8 monoclonal antibodies
WO2000078961A1 (en) 1999-06-23 2000-12-28 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6486301B1 (en) 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
JP2001510035A (ja) 1997-07-16 2001-07-31 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド インターロイキン−２０
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
WO1999007740A2 (en) 1997-08-06 1999-02-18 Zymogenetics, Inc. Lipocalin homologs
US6551799B2 (en) 1999-12-07 2003-04-22 Genentech, Inc. Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
US6576743B1 (en) * 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
IL136076A0 (en) 1997-11-26 2001-05-20 Zymogenetics Inc Mammalian cytokin-like polypeptide -10
EP1047781B1 (en) 1998-01-23 2004-07-28 Immunex Corporation Il-18 receptors
WO1999046379A2 (en) 1998-03-09 1999-09-16 Schering Corporation Human receptor proteins; related reagents and methods
ES2312205T3 (es) 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
US6197582B1 (en) 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
AU5203199A (en) 1998-05-26 1999-12-13 Procter & Gamble Company, The Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
AU5728999A (en) 1998-07-28 2000-02-21 Micromet Ag Heterominibodies
NZ531664A (en) 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
US6472179B2 (en) 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6274710B1 (en) * 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
WO2000024758A1 (en) 1998-10-26 2000-05-04 Ludwig Institute For Cancer Research ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
EP1141008A1 (en) 1998-12-31 2001-10-10 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them
DK1177312T3 (da) 1999-04-28 2008-02-25 Genetics Inst Llc Humane GIL-19/AE289-proteiner og polynukleotider kodende derfor
AU5151100A (en) 1999-05-19 2000-12-05 Incyte Genomics, Inc. Extracellular signaling molecules
AU5047600A (en) 1999-05-27 2000-12-18 Schering Corporation Mammalian interleukin-10 homologs: il-d110 and il-d210
EP1208195A2 (en) 1999-06-15 2002-05-29 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP2241623A3 (en) 1999-07-07 2010-12-01 ZymoGenetics, Inc. Monoclonal antibody against a human cytokine receptor
CA2380355A1 (en) 1999-09-01 2001-03-08 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1230368A2 (en) 1999-11-18 2002-08-14 Schering Corporation Mammalian receptor proteins; related reagents and methods
AU2253301A (en) 1999-12-03 2001-06-12 Zymogenetics Inc. Human cytokine receptor
AU783473B2 (en) 1999-12-23 2005-10-27 Zymogenetics Inc. Soluble interleukin-20 receptor
AU2292601A (en) 1999-12-23 2001-07-03 Zymogenetics Inc. Novel cytokine zcyto18
EP1244708B8 (en) 1999-12-23 2007-03-07 ZymoGenetics, Inc. Method for treating inflammation
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
NZ523122A (en) 2000-06-22 2004-06-25 Smithkline Beecham Corp Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
JP2002015498A (ja) 2000-06-29 2002-01-18 Fujitsu Ltd センス電流の設定方法
DE60123998T2 (de) * 2000-08-08 2007-09-06 Zymogenetics, Inc., Seattle Lösliche zcyctor 11 cytokinrezeptoren
ATE549347T1 (de) 2000-09-08 2012-03-15 Schering Corp Gene von säugetiere, und damit verbundene reagentien, methoden
ATE333888T1 (de) * 2000-09-15 2006-08-15 Zymogenetics Inc Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US20030022827A1 (en) * 2000-09-25 2003-01-30 Bertram Weiss Three new members of the cytokine receptor family class 2
EP1191035A3 (de) 2000-09-25 2002-04-17 Schering Aktiengesellschaft Drei Mitglieder der Zytokinrezeptorfamilie Klasse II
JP2004533811A (ja) 2001-01-12 2004-11-11 ジェネティクス インスティテュート，エルエルシー ２型サイトカインレセプターおよび２型サイトカインレセプターをコードする核酸
EP1390060A2 (en) 2001-01-26 2004-02-25 Eli Lilly And Company Use of lp82 to treat body weight disorders
CA2438238A1 (en) 2001-02-23 2002-09-06 Genetics Institute, Llc. Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
CA2433933A1 (en) 2001-02-28 2002-09-12 Eli Lilly And Company Use of lp82 to treat hematopoietic disorders
EP1370676A4 (en) * 2001-03-02 2004-09-22 Zymogenetics Inc CYTOKIN RECEPTOR FROM MOUSE
US20040086908A1 (en) 2002-03-07 2004-05-06 Chandrasekher Yasmin A. Soluble heterodimeric cytokine receptor
EP1399472B1 (en) 2001-03-09 2009-06-03 ZymoGenetics, Inc. Soluble heterodimeric cytokine receptor
CA2439961A1 (en) 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
AU2002311919B8 (en) 2001-05-11 2007-03-22 Ludwig Institute For Cancer Research Ltd Specific binding proteins and uses thereof
US20040204351A1 (en) 2001-10-22 2004-10-14 Rowlinson Scott William Soluble proteins that inhibit cytokine signal transduction pathways
DE10154579A1 (de) 2001-11-07 2003-05-28 Medigene Ag Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen
CA2467723C (en) 2001-12-17 2011-09-27 Zymogenetics, Inc. Method for treating cervical cancer
US20040236075A1 (en) 2002-07-24 2004-11-25 Laure Dumoutier Novel glass II cytokine receptors, and uses thereof
JP2007525438A (ja) 2003-03-24 2007-09-06 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法
WO2005052001A2 (en) * 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
AU2005299809B2 (en) * 2004-10-22 2010-12-02 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
UA105405C2 (ru) * 2009-11-19 2014-05-12 Мерк Сероно С.А. Гуманизированное антитело против человеческого il-22ra

Similar Documents

Publication Publication Date Title
JP2008517922A5 (https=)
KR102321172B1 (ko) 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ)
Nocker et al. lnterleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease
Kaplanski Interleukin‐18: Biological properties and role in disease pathogenesis
Nonaka et al. Distinct Immunohistochemical ocalization of 11-4 in Human Inflamed Airway Tissues
Raqib et al. Persistence of local cytokine production in shigellosis in acute and convalescent stages
DE69933115T2 (de) Verwendung eines antagonisten antikörpers gegen den entzündungsmediator oncostatin m (osm)
JP4927762B2 (ja) Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
EP2021016B1 (en) Cxcl-13 antagonists and tnf-alpha antagonists for use in a combination therapy
PT2423230E (pt) Membro de ligação para o recetor de gm-csf
JP2005512507A (ja) 抗炎症剤としてのｈｍｇフラグメントの使用
JP2005512507A6 (ja) 抗炎症剤としてのｈｍｇフラグメントの使用
KR101681331B1 (ko) 치료를 위한 ｇｍ-ｃｓｆ 및 ｉｌ-17의 억제제
JP2019534282A (ja) 抗ｉｌ−３３抗体およびその使用
Ogushi et al. Autoantibodies to IL-1 alpha in sera from rapidly progressive idiopathic pulmonary fibrosis
US20070280936A1 (en) Method for treating psoriasis
JP2011502170A (ja) 変形性関節症疾患の治療又は予防のためのトール様受容体４拮抗物質の使用
US20090214549A1 (en) Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field
Kajikawa et al. Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1: cytokines that mediate leukocyte recruitment to the lungs
CA2682666A1 (en) Cxcl13 antagonists and their use for the treatment of inflammatory diseases
Andersen et al. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis
Kim et al. Proteinase 3-processed form of the recombinant IL-32 separate domain
CN118909123A (zh) 人源化抗人cd132单克隆抗体及其应用
JP4257946B2 (ja) 可溶化ヒトインターロイキン１８レセプターα，その測定方法，測定用キット及び医薬組成物
JP2009507511A (ja) 炎症を診断および治療するための組成物および方法